Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction

World Journal of Surgery

Volumn 30, Issue 3, 2006, Pages 364-371

  Yuasa, Norihiro ^a,b   Miyake, Hideo ^a   Yamada, Tatsuharu ^a   Ebata, Tomoki ^a   Nimura, Yuji ^a   Hattori, Tatsuo ^b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; PREVALENCE; SURGICAL TECHNIQUE; SURVIVAL TIME; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; JAPAN; LYMPHATIC METASTASIS; MALE; STATISTICS, NONPARAMETRIC; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 32944467167     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-005-0434-x     Document Type: Article

References (37)

1. Clark GW, Peters JH, Ireland AP, et al. Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma. Ann Thorac Surg 1994;58:646-653.
2. Wright CD, Mathisen DJ, Wain JC, et al. Evolution of treatment strategies for adenocarcinoma of the esophagus and gastroesophageal junction. Ann Thorac Surg 1994;58:1574-1578.
3. Millikan KW, Silverstein J, Hart V, et al. A 15-year review of esophagectomy for carcinoma of the esophagus and cardia. Arch Surg 1995;130:617-624.
4. Tachimori Y, Kato H, Watanabe H, et al. Difference between carcinoma of the lower esophagus and the cardia. World J Surg 1996;20:507-510.
5. Nishi M, Nomura H, Kajisa T, et al. Surgical problem of carcinoma in the esophagogastric junction. Stomach and Intestine 1978;13:1497-1507. (in Japanese with English abstract).
6. Nakane Y, Okamura S, Boku T, et al. Prognostic differences of adenocarcinoma arising from the cardia and the upper third of the stomach. Am Surg 1993;59:423-429.
7. Ohno S, Tomisaki S, Oiwa H, et al. Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach. J Am Coll Surg 1995;180:577-582.
8. Okabayashi T, Gotoda T, Kondo H, et al. Early carcinoma of the gastric cardia in Japan: is it different from that in the West? Cancer 2000;89:2555-559.
9. Misumi A, Murakami A, Harada K, et al. Definition of carcinoma of the gastric cardia. Langenbecks Arch Chir 1989;374:221-226.
10. Siewert JR, Stein HJ. Carcinoma of the cardia: carcinoma of the gastroesophageal junction - classification, pathology and extent of resection. Dis Esophagus 1996;9:173-182.
11. Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990;62:440-443.
12. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-2053.
13. Ozawa S, Ando N, Kitagawa Y, et al. Does incidence of carcinoma of the esophagogastric junction increase. Nippon Geka Gakkai Zasshi 1998;99:542-546 (in Japanese with English abstract).
14. Kodera Y, Yamamura Y, Shimizu Y, et al. Adenocarcinoma of the gastroesophageal junction in Japan: relevance of Siewert's classification applied to 177 cases resected at a single institution. J Am Coll Surg 1999;189:594-601.
15. Nakamura T, Ide H, Eguchi R, et al. Adenocarcinoma of the esophagogastric junction: a summary of responses to a questionnaire on adenocarcinoma of the esophagus and the esophagogastric junction in Japan. Dis Esophagus 2002;15:219-225.
16. Ichikura T, Ogawa T, Kawabata T, et al. Is adenocarcinoma of the gastric cardia a distinct entity independent of subcardial carcinoma? World J Surg 2003;27:334-338.
17. Siewert JR, Feith M, Werner M, et al. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical / topographic classification in 1,002 consecutive patients. Ann Surg 2000;232:353-361.
18. Mariette C, Castel B, Toursel H, et al. Surgical management of and long-term survival after adenocarcinoma of the cardia. Br J Surg 2002;89:1156-1163.
19. Ito H, Clancy TE, Osteen RT, et al. Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg. 2004;199:880-886.
20. Fein M, Fuchs KH, Ritter MP, et al. Application of the new classification for cancer of the cardia. Surgery 1998;124:707-713.
21. Peracchia A, Bonavina L, Incarbone R, et al. Results of surgical therapy in patients with adenocarcinoma of the esophagus and cardia. Gastric Cancer 1999;2:89-94.
22. Hulscher JB, Van Sandick JW, Offerhaus GJ, et al. Prospective analysis of the diagnostic yield of extended en bloc resection for adenocarcinoma of the esophagus or gastric cardia. Br J Surg 2001;88:715-719.
23. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 2nd English edition. Gastric Cancer 1998;1:10-24.
24. Sobin LH, Wittekind C, International Union Against Cancer. (UICC), eds, TNM Classification of Malignant Tumors. 5th ed. New York: John Wiley & Sons, Inc., 1997.
25. Fleming ID, American Joint Committee on Cancer Classification (AJCC), eds, AJCC Cancer Staging Manual. Philadelphia: Lippincott Williams & Wilkins, 1997.
26. Akiyama H, Miyazono H, Tsurumaru M, et al. Thoracoabdominal approach for carcinoma of the cardia of the stomach. Am J Surg 1979;137:345-349.
27. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
28. Gehan EA. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 1965;52:203-224.
29. Dresner SM, Lamb PJ, Bennett MK, et al. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery 2001;129:103-109.
30. Aikou T, Shimazu H. Difference in main lymphatic pathways from the lower esophagus and gastric cardia. Jpn J Surg 1989;19:290-295.
31. De Manzoni G, Pedrazzani C, Pasini F, et al. Pattern of recurrence after surgery in adenocarcinoma of the gastroesophageal junction. Eur J Surg Oncol 2003;29:506-510.
32. Sadahiro S, Suzuki T, Ishikawa K, et al. Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma: a randomized control trial. Cancer 2004;100:590-597.
33. Sons HU, Borchard F. Cancer of the distal esophagus and cardia. Incidence, tumorous infiltration, and metastatic spread. Ann Surg 1986;203:188-195.
34. Husemann B. Cardia carcinoma considered as a distinct clinical entity. Br J Surg 1989;76:136-139.
35. Stipa S, Di Giorgio A, Ferri M. Surgical treatment of adenocarcinoma of the cardia. Surgery 1992;111:386-393.
36. Mattioli S, Di Simone MP, Ferruzzi L, et al. Surgical therapy for adenocarcinoma of the cardia: modalities of recurrence and extension of resection. Dis Esophagus 2001;14:104-109.
37. Heidl G, Langhans P, Mellin W, et al. Adenocarcinomas of esophagus and cardia in comparison with gastric carcinoma. J Cancer Res Clin Oncol 1993;120:95-99.